Unknown

Dataset Information

0

Functional outcomes in the inpatient rehabilitation setting following severe COVID-19 infection.


ABSTRACT:

Objective

To characterize the functional impairments of a cohort of patients undergoing inpatient rehabilitation after surviving severe COVID-19 illness, in order to better understand the ongoing needs of this patient population.

Methods

This study consisted of a retrospective chart review of consecutive patients hospitalized for COVID-19 and admitted to a regional inpatient rehabilitation hospital from April 29th to May 22nd, 2020. Patient demographics, clinical characteristics and complications from acute hospitalization were examined. Measures of fall risk (Berg Balance Scale), endurance (6 Minute Walk Test), gait speed (10 Meter Walk Test), mobility (transfer and ambulation independence), cognition, speech and swallowing (American Speech and Hearing Association National Outcomes Measurement System Functional Communication Measures) were assessed at rehabilitation admission and discharge.

Results

The study population included 29 patients and was 70% male, 58.6% white and with a mean age of 59.5. The mean length of acute hospitalization was 32.2 days with a mean of 18.7 days intubated. Patients spent a mean of 16.7 days in inpatient rehabilitation and 90% were discharged home. Patients demonstrated significant improvement from admission to discharge in measures of fall risk, endurance, gait speed, mobility, cognition, speech and swallowing, (p< 0.05). At discharge, a significant portion of the population continued to deficits in cognition (attention 37%; memory 28%; problem solving 28%), balance (55%) and gait speed (97%).

Conclusion

Patients admitted to inpatient rehabilitation after hospitalization with COVID-19 demonstrated deficits in mobility, cognition, speech and swallowing at admission and improved significantly in all of these domains by discharge. However, a significant number of patients exhibited residual deficits at discharge highlighting the post-acute care needs of this patient population.

SUBMITTER: Olezene CS 

PROVIDER: S-EPMC8011729 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10153306 | biostudies-literature
| S-EPMC9821470 | biostudies-literature
| S-EPMC8206980 | biostudies-literature
| S-EPMC5488554 | biostudies-other
| S-EPMC5330160 | biostudies-literature
| S-EPMC8183585 | biostudies-literature
| S-EPMC7857995 | biostudies-literature
| S-BSST563 | biostudies-other
| S-EPMC11017048 | biostudies-literature
| S-BSST416 | biostudies-other